ClinicalTrials.gg
Enrolling by invitationNCT06096831Updated Nov 12, 2026

Living With Stroke - Sustainable Utilization of Healthcare Services

An observational study in Stroke, Cerebrovascular Disorders and Cerebrovascular Accident, sponsored by University of Haifa. Enrolling by invitation at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by University of Haifa · Observational

How we know

Updated Nov 12, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
240
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 127 studies in Stroke with a site in Israel — 12 open to participants now, 21 under way, 3 of them phase 3. Stroke · Israel.

Planned enrollment
13th of 36
240 · median 196
Started
2023
with 5 others
Observational
38 of 127
3 open now
Primary completion
2027-03
later than 13 of 20 live
Registered
114th of 127
by date
Lead sponsor
7 of 127
University of Haifa

Among the 127 studies in Stroke with a site in Israel, this one is the 13th largest by planned enrollment of the 36 observational ones that give a count, is one of 6 that started in 2023, is one of 38 observational ones, reaches primary completion later than 13 of the 20 other live ones, and was the 114th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

12 of the 127 studies in Stroke with a site in Israel are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 127 studies in Stroke with a site in Israel, or all of them as a file.
02

Study summary

The proposed study will generate a national mapping of healthcare utilization patterns in people post-stroke in the chronic phase living in the community; examine the associations between individual-level characteristics, health outcomes and healthcare utilization; and will describe patients' perspectives on their needs for health services and their experiences of using them.

The study will use mixed-methods methodology (quantitative and qualitative) and will proceed in three parts. In part 1, data will be extracted retrospectively from electronic medical records of of Clalit Health Services, covering all patients with a stroke diagnosis. In part 2, a sub-sample of 240 patients will be asked to answer standardized questionnaires. In part 3, a sub-sample of 20 participants will participate in in-depth, semi-structured interviews.

Read the detailed description

Stroke is the leading cause of long-term disability worldwide. Although healthcare services can have a crucial role in mitigating the long-term multidimensional disabilities caused by stroke, most medical and rehabilitative services are currently directed towards the acute phase of the disease up to six months after its occurrence. Healthcare services in the chronic phase are inadequately structured, and stroke survivors in the community report lack of continuity of care and a sense of abandonment. Long-term utilization patterns of healthcare service by post-stroke persons are unknown.

Based on data to be collected from people in the chronic post-stroke phase living in the community, the study goals are to (1) generate a national mapping of patterns of healthcare utilization; (2) examine associations between individual-level characteristics and healthcare utilization; and (3) describe patients' perspectives on their needs for health services and their experience of using them.

A 'Mixed methods' research combining qualitative and quantitative methods will be conducted.The research will include 3 parts: Part 1 of the study is retrospective study based on data extracting from electronic medical records of Clalit Health Services on healthcare utilization of people post-stroke (app. 40,000 people); Part 2 is a cross-sectional study based on a sub-group of 240 people post-stroke that will be asked to answer standardized questionnaires on face to face meeting aimed to capture individual determinants of healthcare utilization; Part 3 will include in-depth interviews with 20 people post-stroke to capture patients' perspectives on their post-stroke healthcare needs and their experience of using healthcare services.

03

Conditions studied

  • Stroke
  • Cerebrovascular Disorders
  • Cerebrovascular Accident
  • Healthcare Utilization

Keywords

  • Post-stroke
  • Healthcare utilization
  • Continuity of care
  • Rehabilitation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Post-stroke patients living in the community. At least one year after the stroke occurred. An estimated number of approximately 40,000 patients nationwide (Part 1) and 240 patients hospitalized at the 'Carmel' Medical Center (Part 2\&3).

Eligibility criteria

Inclusion Criteria for the retrospective study (Part 1):

  • People diagnosed with stroke (First stroke occurred between 2010-2022)
  • At least one year after the event
  • Living in the community
  • Aged 18 and above
  • Insured by HMO (Clalit health services)

Exclusion Criteria for the retrospective study (Part 1):

  • Stroke chronicity of less than a year
  • Diagnosis of (Transient Ischemic Attack)

Inclusion Criteria for the cross-sectional and qualitative study (Parts 2\&3):

  • People diagnosed with stroke
  • Hospitalized for a first stroke at the 'Carmel' Medical Center between 2010-2022
  • Understand Hebrew/ Arabic/ Russian in a way that allows them to understand the consent form and answer the survey questions.

Exclusion Criteria for the cross-sectional and qualitative study (Parts 2\&3):

  • Stroke chronicity of less than a year the study
  • Transient ischemic attack (TIA)
  • Patients who have a guardian, a nursing condition as a result of diseases other than stroke or other serious background diseases that impair function, people with communication difficulties that do not allow answering questionnaires or to be interviewed.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

TIA (transient ischaemic attack)

A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.

Stroke symptoms need emergency care at once, even if they go away.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
240 participants (estimated)
Patient registry
No

Groups and cohorts

  • Post-Stroke patients at chronic phase living in the community

    The data will be extracted from medical records of all people who are at least one year after a stroke, live in the community and are insured by Health maintenence Organization (HMO).In the first part we expect to extract data of approximately 40,000 patients . In the second part, a sub sample of 240 patients will be recruited to answer standardized questionnaires. In the third part, a sub-sample from part 2, of 20 people will be interviewed.

06

What researchers measure

Primary outcomes

  1. Visits to a neurologist

    Monitoring the number of annual visits to a neurologist in the chronic phase of the disease. Extraction and analysis of data from Clalit's electronic medical records (EMR) of all insured patients who had a stroke. An estimated number of 40,000 patients post-stroke.

    Time frame: 1 year

  2. Use of physical therapy services

    Monitoring the number of annual visits to physical therapy services in the chronic phase of the disease. Extraction and analysis of data from Clalit's electronic medical records (EMR) of all insured patients who had a stroke. An estimated number of 40,000 patients post-stroke.

    Time frame: 1 year

  3. Stroke impact Scale - SIS 3.0

    The SIS-3.0 questionnaire evaluate how the stroke has impacted patients' health and life. It composed of 59 items investigating 8 domains (strength, hand function, mobility, activities of daily living, emotion, memory, communication, social participation) and also assesses the degree of recovery from the stroke. Range of scores is 0-100. Each item is scaling by a 5-point scale from 1 to 5. The questionnaire will be evaluated for a sub-sample of 250 patients.

    Time frame: 1 hour

  4. Visits to the emergency medicine center and urgent hospitalization data from Clalit's electronic medical records (EMR) of all insured patients who had a stroke. An estimated number of 40,000 patients post-stroke.

    Monitoring the number of annual visits to the emergency medicine center and the number of urgent hospitalization in the chronic phase of the disease. Extraction and analysis of data from Clalit's electronic medical records (EMR) of all insured patients who had a stroke. An estimated number of 40,000 patients post-stroke.

    Time frame: 1 year

Secondary outcomes

  1. Use of occupational therapy services

    Monitoring the number of annual visits to occupational therapy services in the chronic phase of the disease. Extraction and analysis of data from Clalit's electronic medical records (EMR) of all insured patients who had a stroke. An estimated number of 40,000 patients post-stroke.

    Time frame: 1 year

  2. Use of speech-language therapy services

    Monitoring the number of annual visits to speech-language therapy services in the chronic phase of the disease. Extraction and analysis of data from Clalit's electronic medical records (EMR) of all insured patients who had a stroke. An estimated number of 40,000 patients post-stroke.

    Time frame: 1 year

  3. Recurrent stroke

    Follow-up of recurrent stroke in the chronic phase of the disease.

    Time frame: 1 year

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Nov 2023 (actual). Primary completion is estimated for Mar 2027, 40 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 12, 2026: primary completion Mar 2026 → Mar 2027 and completion Dec 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 8, 2023
First posted
Oct 24, 2023
StartActual
Nov 15, 2023
Primary completionEst.
Mar 2027was Mar 2026
CompletionEst.
Dec 2027was Dec 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Mar 2026→Mar 2027
Nov 12, 2026
Study completion
Dec 2026→Dec 2027
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Primary completion Mar 2026→Mar 2027
    Study completion Dec 2026→Dec 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06096831
Collaborators
Ben-Gurion University of the Negev, Clalit Health Services, Carmel Medical Center
Responsible party
Sponsor
First posted
Oct 24, 2023
Start date
Nov 15, 2023
Primary completion
Mar 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Nov 12, 2026

Study contacts

Michal Kafri, PhD
principal investigator · University of Haifa
Sivan Bloch, M.D
principal investigator · Carmel Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion